SEC Comment Letter for Apollo Endosurgery, Inc. (CIK 0001251769) — Aug 18, 2020
Apollo Endosurgery, Inc. (CIK 0001251769)
Date: Aug. 18, 2020 · CIK: 0001251769 · Accession: 0000000000-20-007601
AI Filing Summary & Sentiment
File numbers found in text: 333-245652
Letter
United States securities and exchange commission logo August 18, 2020 Todd Newton Chief Executive Officer Apollo Endosurgery, Inc. 1120 South Capital of Texas Highway Building 1, Suite 300 Austin, Texas 78746 Re:Apollo Endosurgery, Inc. Registration Statement on Form S-3 Filed August 13, 2020 File No. 333-245652 Dear Mr. Newton: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at (202) 551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: John T. McKenna
Show Raw Text
United States securities and exchange commission logo
August 18, 2020
Todd Newton
Chief Executive Officer
Apollo Endosurgery, Inc.
1120 South Capital of Texas Highway
Building 1, Suite 300
Austin, Texas 78746
Re:Apollo Endosurgery, Inc.
Registration Statement on Form S-3
Filed August 13, 2020
File No. 333-245652
Dear Mr. Newton:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at (202) 551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: John T. McKenna